Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients

References

• Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Habibi S, Gharagozlou M, et al. 2018. Fourth update on the iranian national registry of primary immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 38:816–32.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Movahedi M, Hamidieh AA, Behniafard N, et al. 2019. National consensus on diagnosis and management guidelines for primary immunodeficiency. Immunol Genet J. 2:1–21.
   Google Scholar
• Aghamohammadi A, Akrami SM, Yaghmaie M, Rezaei N, Azizi G, Yaseri M, Nosrati H, Zaki-Dizaji M. 2018. Individual radiosensitivity assessment of the families of ataxia-telangiectasia patients by G2-checkpoint abrogation. Sultan Qaboos Univ Med J. 18:e440–e46.
   PubMedGoogle Scholar
• Aghamohammadi A, Imai K, Moazzami K, Abolhassani H, Tabatabaeiyan M, Parvaneh N, Nasiri Kalmarzi R, Nakagawa N, Oshima K, Ohara O. 2010. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. J Investig Allergol Clin Immunol. 20:442–45.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, Parvaneh N, Zeiaee V, Mirsaeed-Ghazi B, Chavoushzadeh Z, et al. 2014. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 34:478–90.
   PubMed Web of Science ®Google Scholar
• Ament ME. 1969. Respiratory complications of ataxia-telangiectasia. N Engl J Med. 281:1019.
   PubMed Web of Science ®Google Scholar
• Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. 2019a. Ataxia-telangiectasia: A review of clinical features and molecular pathology. Pediatr Allergy Immunol. 30(3):277–88.
   PubMed Web of Science ®Google Scholar
• Amirifar P, Yazdani R, Moeini Shad T, Ghanadan A, Abolhassani H, Lavin M, Sotoudeh S, Aghamohammadi A. 2019b. Cutaneous granulomatosis and class switching defect as a presenting sign in ataxia-telangiectasia: first case from the national Iranian registry and review of the literature. Immunol Invest. 48:1–14.
   PubMed Web of Science ®Google Scholar
• Azarsiz E, Karaca NE, Gunaydin NC, Gulez N, Ozturk C, Aksu G, Genel F, Kutukculer N. 2014. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia? Int J Immunopathol Pharmacol. 27:421–27.
   PubMed Web of Science ®Google Scholar
• Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:499–506.
   PubMed Web of Science ®Google Scholar
• Blom M, Schoenaker MHD, Hulst M, de Vries MC, Weemaes CMR, Willemsen MAAP, Henneman L, van der Burg M. 2019. Dilemma of reporting incidental findings in newborn screening programs for SCID: parents’ perspective on ataxia telangiectasia. Front Immunol. 10:2438.
   PubMed Web of Science ®Google Scholar
• Bobba N, Kaplan MS. 2005. Immunodeficiency and infections in ataxia-telangiectasia. Pediatrics. 116:568–68.
   Google Scholar
• Bott L, Lebreton JP, Thumerelle C, Cuvellier JC, Deschildre A, Sardet A. 2007. Lung disease in ataxia‐telangiectasia. Acta Paediatr. 96:1021–24.
   PubMed Web of Science ®Google Scholar
• Buckley RH. 2004. Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev. 5:S225–S33.
   PubMedGoogle Scholar
• Canny GJ, Roifman C, Weitzman S, Braudo M, Levison H. 1988. A pulmonary infiltrate in a child with ataxia telangiectasia. Ann Allergy. 61(422–3):66–68.
   Google Scholar
• Chaudhary MW, Al-Baradie RS. 2014. Ataxia-telangiectasia: future prospects. Appl Clin Genet. 7:159–67.
   PubMedGoogle Scholar
• Chen L, Guo L, Tian J, Zheng B, Han S. 2010. Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background. Clin Exp Immunol. 159:169–75.
   PubMed Web of Science ®Google Scholar
• Chiam LY, Verhagen MM, Haraldsson A, Wulffraat N, Driessen G-J, Netea MG, Weemaes CMR, Seyger MMB, van Deuren M. 2011. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology. 223:13–19.
   PubMed Web of Science ®Google Scholar
• Cohen LE, Tanner DJ, Schaefer HG, Levis WR. 1984. Common and uncommon cutaneous findings in patients with ataxia-telangiectasia. J Am Acad Dermatol. 10:431–38.
   PubMed Web of Science ®Google Scholar
• Crawford TO, Skolasky RL, Fernandez R, Rosquist KJ, Lederman HM. 2006. Survival probability in ataxia telangiectasia. Arch Dis Child. 91:610–11.
   PubMed Web of Science ®Google Scholar
• Driessen GJ, Ijspeert H, Weemaes CM, Haraldsson A, Trip M, Warris A, van der Flier M, Wulffraat N, Verhagen MMM, Taylor MA, et al. 2013. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. J Allergy Clin Immunol. 131:1367–75.e9.
   PubMed Web of Science ®Google Scholar
• Fiorilli M, Businco L, Pandolfi F, Paganelli R, Russo G, Aiuti F. 1983. Heterogeneity of immunological abnormalities in ataxia-telangiectasia. J Clin Immunol. 3:135–41.
   PubMed Web of Science ®Google Scholar
• Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NGJ, Lange K, et al. 1988. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 336:577–80.
   PubMed Web of Science ®Google Scholar
• Ghiasy S, Parvaneh L, Azizi G, Sadri G, Zaki Dizaji M, Abolhassani H, Aghamohammadi A. 2017. The clinical significance of complete class switching defect in ataxia telangiectasia patients. Expert Rev Clin Immunol. 13:499–505.
   PubMed Web of Science ®Google Scholar
• Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Harrison RV, Passamani PP. 2013. Otitis media: diagnosis and treatment. Am Fam Physician. 88:435–40.
   PubMed Web of Science ®Google Scholar
• Herve M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, Meffre E. 2007. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med. 204:1583–93.
   PubMed Web of Science ®Google Scholar
• Islam KB, Baskin B, Nilsson L, Hammarström L, Sideras P, Smith CI. 1994. Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol. 152:1442–52.
   PubMed Web of Science ®Google Scholar
• Jesus AA, Duarte AJ, Oliveira JB. 2008. Autoimmunity in hyper-IgM syndrome. J Clin Immunol. 28(Suppl 1):S62–6.
   PubMed Web of Science ®Google Scholar
• Jozwiak S. 2005. Ataxia-telangiectasia. Emedicine. Com. 13.
   Google Scholar
• Kanegae MP, Barreiros LA, Sousa JL, Brito MA, Oliveira Junior EB, Soares LP, Mazzucchelli JT, Fernandes DQ, Hadachi SM, Holanda SM, et al. 2017. Newborn screening for severe combined immunodeficiencies using trecs and krecs: second pilot study in Brazil. Rev Paul Pediatr. 35:25–32.
   PubMedGoogle Scholar
• Lehman H. 2014. Skin manifestations of primary immune deficiency. Clin Rev Allergy Immunol. 46:112–19.
   PubMed Web of Science ®Google Scholar
• Mahmoodi M, Abolhassani H, Mozdarani H, Rezaei N, Azizi G, Yazdani R, Farzanfar F, Rafiemanesh H, Mohagheghi M-A, Divsalar K, et al. 2018. In vitro chromosomal radiosensitivity in patients with common variable immunodeficiency. Cent Eur J Immunol. 43(2):155–61.
   PubMed Web of Science ®Google Scholar
• McGrath-Morrow SA, Gower WA, Rothblum-Oviatt C, Brody AS, Langston C, Fan LL, Lefton-Greif MA, Crawford TO, Troche M, Sandlund JT, et al. 2010. Evaluation and management of pulmonary disease in ataxia-telangiectasia. Pediatr Pulmonol. 45(9):847–59.
   PubMed Web of Science ®Google Scholar
• Meyts I, Weemaes C, De Wolf-Peeters C, Proesmans M, Renard M, Uyttebroeck A, De Boeck K. 2003. Unusual and severe disease course in a child with ataxia-telangiectasia. Pediatr Allergy Immunol. 14(4):330–33.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16(3):1215.
   PubMed Web of Science ®Google Scholar
• Modell V, Orange JS, Quinn J, Modell F. 2018. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 66(3):367–80.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad P, Abolhassani H, Aghamohammadi A, Pourhamdi S, Ghosh S, Sadeghi B, Nasiri Kalmarzi R, Durandy A, Borkhardt A. 2015. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM. J Immunoassay Immunochem. 36(1):16–26.
   PubMedGoogle Scholar
• Nissenkorn A, Levy-Shraga Y, Banet-Levi Y, Lahad A, Sarouk I, Modan-Moses D. 2016. Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort. Pediatr Res. 79(6):889–94.
   PubMed Web of Science ®Google Scholar
• Noordzij JG, Wulffraat NM, Haraldsson A, Meyts I, Veer LJV, Hogervorst FBL, Warris A, Weemaes CMR. 2009. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child. 94(6):448–49.
   PubMed Web of Science ®Google Scholar
• Nourizadeh M, Shakerian L, Borte S, Fazlollahi M, Badalzadeh M, Houshmand M, Alizadeh Z, Dalili H, Rashidi-Nezhad A, Kazemnejad A, et al. 2018. Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran. Scand J Immunol. 88(2):e12699.
   Web of Science ®Google Scholar
• Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. 2004a. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 144(4):505–11.
   PubMed Web of Science ®Google Scholar
• Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. 2004b. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 144:505–11.
   PubMed Web of Science ®Google Scholar
• Painter RB, Young BR. 1980. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A. 77:7315–17.
   PubMed Web of Science ®Google Scholar
• Pan Q, Petit-Frere C, Lahdesmaki A, Gregorek H, Chrzanowska K, Hammarström L. 2002. Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol. 32:1300–08.
   PubMed Web of Science ®Google Scholar
• Rawat A, Imai K, Suri D, Gupta A, Bhisikar S, Saikia B, Minz RW, Sehgal S, Singh S. 2016. Ataxia telangiectasia masquerading as hyper IgM syndrome. Indian J Pediatr. 83(3):270–71.
   PubMed Web of Science ®Google Scholar
• Razaghian A, Ziaee V, Momen T, Shariat M. 2019. Misclassification of ataxia telangiectasia with hyper IgM immune profile. Immunol Genet J. 2:147–52.
   Google Scholar
• Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. 2016. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 11:159.
   PubMed Web of Science ®Google Scholar
• Sanal O, Ersoy F, Yel L, Tezcan I, Metin A, Özyürek H, Gariboglu S, Fikrig S, Berkel AI, Rijkers GT, et al. 1999. Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. J Clin Immunol. 19:326–34.
   PubMed Web of Science ®Google Scholar
• Schalch DS, McFarlin DE, Barlow MH. 1970. An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med. 282:1396–402.
   PubMed Web of Science ®Google Scholar
• Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, Scheible R, Rusch S, Gasteiger LM, Grimbacher B, et al. 2019. The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 7:1763–1770.
   Google Scholar
• Soresina A, Meini A, Lougaris V, Cattaneo G, Pellegrino S, Piane M, Darra F, Plebani A. 2008. Different clinical and immunological presentation of ataxia-telangiectasia within the same family. Neuropediatrics. 39:43–45.
   PubMed Web of Science ®Google Scholar
• Stray-Pedersen A, Borresen-Dale AL, Paus E, Lindman CR, Burgers T, Abrahamsen TG. 2007. Alpha fetoprotein is increasing with age in ataxia-telangiectasia. Eur J Paediatr Neurol. 11:375–80.
   PubMed Web of Science ®Google Scholar
• Stray-Pedersen A, Jonsson T, Heiberg A, Lindman CR, Widing E, Aaberge IS, Borresen-Dale AL, Abrahamsen TG. 2004. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clin Exp Immunol. 137:179–86.
   PubMed Web of Science ®Google Scholar
• Su Y, Swift M. 2000. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med. 133:770–78.
   PubMed Web of Science ®Google Scholar
• Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. 1986. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet. 39:573–83.
   PubMed Web of Science ®Google Scholar
• Tangsinmankong N, Wayne AS, Howenstine MS, Washington KR, Langston C, Gatti RA, Good RA, Nelson Jr RP. 2001. Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia. J Pediatr. 138:939–41.
   PubMed Web of Science ®Google Scholar
• Teive HA, Moro A, Moscovich M, Arruda WO, Munhoz RP, Raskin S, Ashizawa T. 2015. Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci. 355:3–6.
   PubMed Web of Science ®Google Scholar
• Upadhyaya SA, Mody R, Walkovich K, Hutchinson RJ, Sandlund JT, Connelly JA. 2017. Ataxia telangiectasia and cancer predisposition: challenges in management. J Pediatr Hematol Oncol. 40:483–486.
   Google Scholar
• van Os NJH, Jansen AFM, van Deuren M, Haraldsson A, van Driel NTM, Etzioni A, van der Flier M, Haaxma CA, Morio T, Rawat A, et al. 2017. Ataxia-telangiectasia: immunodeficiency and survival. Clin Immunol. 178:45–55.
   PubMed Web of Science ®Google Scholar
• Waldmann TA. 1982. Immunological abnormalities in ataxia-telangiectasia. Ataxia-telangiectasia: A cellar and molecular link between cancer neuropthology and immune deficiency. 37:37–52.
   Google Scholar
• Yu K, Lieber MR. 2019. Current insights into the mechanism of mammalian immunoglobulin class switch recombination. Crit Rev Biochem Mol Biol. 54:333–51.
   PubMed Web of Science ®Google Scholar
• Zaki-Dizaji M, Akrami SM, Abolhassani H, Rezaei N, Aghamohammadi A. 2017. Ataxia telangiectasia syndrome: moonlighting ATM. Expert Rev Clin Immunol. 13:1155–72.
   PubMed Web of Science ®Google Scholar
• Zaki-Dizaji M, Akrami SM, Azizi G, Abolhassani H, Aghamohammadi A. 2018. Inflammation, a significant player of ataxia-telangiectasia pathogenesis? Inflamm Res. 67:559–70.
   PubMed Web of Science ®Google Scholar